Biotech & Healthtech Funding May–June 2026: ADCs, Immune Mapping, and AI Care
Anagram Therapeutics, Ona Therapeutics, IMU Biosciences, and Garner Health show biotech and healthtech capital in 2026 favoring validated science and AI-enabled care.
investment-strategies
Climate & Energy Funding May–June 2026: Fusion, Grids, and the Physical Economy
Helion's $465M fusion round and Gigascale Capital's $250M fund show climate capital in 2026 favoring hard energy infrastructure with a path to cheaper, cleaner output.
Creator Fund's $56M: Backing Europe's Scientific Founders Early
Creator Fund closed $56M in June 2026 to back Europe's scientific and technical founders at the earliest stages — capital aimed at deeptech at the source.
Cybersecurity Funding May–June 2026: Cyera's $12B and the AI 'Trust Layer'
Cyera's $600M at a $12B valuation shows security capital in 2026 flowing to the 'trust layer' that governs what enterprise AI can access and do.
Cyera's $600M at $12B: Building the 'Trust Layer' for Enterprise AI
Cyera raised $600M at a $12B valuation in June 2026, quadrupling its worth in 18 months as the data-security platform governing what enterprise AI can access.
Fintech Funding May–June 2026: Ramp's $44B Leap and the AI Premium
Ramp's $750M at $44B, Corgi's stacked insurtech rounds, and India's Scapia show fintech is fundable again in 2026 — but only with a credible AI story.